|
Market Closed -
Nasdaq
21:00:00 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 147.50 USD | -1.04% |
|
-2.56% | +20.17% |
| 09-28 | Mirum's liver infection drug lowers virus levels in late-stage study | RE |
| 09-25 | HEALTH ROUNDS-Genetic discovery yields clues toward reversal of Alzheimer's brain damage | RE |
| Market Cap | 185B 164B 153B 140B 263B 17,800B 267B 1,853B 719B 9,070B 694B 679B 29,210B | P/E 2026 * |
-44.6x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 202B 179B 167B 153B 287B 19,412B 291B 2,021B 784B 9,891B 757B 740B 31,856B | EV / Sales 2026 * |
6.57x | EV / Sales 2027 * | 5.93x |
| Free-Float |
99.88% | Yield 2026 * |
2.23% | Yield 2027 * | 2.27% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Xetra
| GIS | Delayed | |
|
Tradegate
| GIS | Real-time | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| GIS | Delayed | |
|
London S.E.
| 0QYQ | Delayed | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -1.04% | ||
| 1 week | -2.56% | ||
| Current month | -1.04% | ||
| 1 month | +0.79% | ||
| 3 months | +16.75% | ||
| 6 months | +5.83% | ||
| Current year | +20.17% |
| 1 week | 147.18 |  | 152.74 |
| 1 month | 142.94 | | 154.2 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 28/02/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 31/10/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 17/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 18/08/2016 |
| Director/Board Member | 73 | 31/12/2017 | |
Harish Manwani
BRD | Director/Board Member | 72 | 08/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/09/26 | Exercice | Controller/Auditor | 5,214 | 0.0004% | ||
| 15/09/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 15/09/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.04% | -2.56% | +32.88% | +96.82% | 185B | |
| -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | |
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | |
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | |
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | |
| -1.26% | -0.89% | -27.46% | -61.17% | 170B | |
| Average | -0.80% | -0.29% | +28.33% | +45.49% | 393.4B | |
| Weighted average by Cap. | -0.47% | -0.32% | +35.22% | +63.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.7B 27.32B 25.49B 23.27B 43.65B 2,957B 44.33B 308B 119B 1,507B 115B 113B 4,852B | 32.68B 29.08B 27.14B 24.77B 46.47B 3,148B 47.19B 328B 127B 1,604B 123B 120B 5,165B |
| Net income | -4.27B -3.8B -3.55B -3.24B -6.08B -412B -6.17B -42.86B -16.62B -210B -16.05B -15.7B -676B | 10.28B 9.14B 8.53B 7.79B 14.61B 990B 14.84B 103B 39.96B 504B 38.58B 37.74B 1,624B |
| Net Debt | 16.75B 14.9B 13.9B 12.69B 23.81B 1,613B 24.18B 168B 65.12B 822B 62.87B 61.5B 2,647B | 9.12B 8.12B 7.58B 6.92B 12.97B 879B 13.18B 91.48B 35.48B 448B 34.26B 33.51B 1,442B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | US$147.50 | -1.04% | 4,326,238 |
| 30/09/26 | US$149.05 | -1.47% | 5,357,405 |
| 29/09/26 | US$151.28 | -0.61% | 5,322,556 |
| 28/09/26 | US$152.21 | +0.85% | 5,081,993 |
| 25/09/26 | US$150.93 | +0.83% | 5,284,284 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
